IRF3-mediated pathogenicity in a murine model of human hepatitis A.

Lu Sun, You Li, Ichiro Misumi, Olga González-López, Lucinda Hensley, John M Cullen, David R McGivern, Mami Matsuda, Ryosuke Suzuki, Ganes C Sen, Asuka Hirai-Yuki, Jason K Whitmire, Stanley M Lemon
Author Information
  1. Lu Sun: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  2. You Li: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  3. Ichiro Misumi: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. ORCID
  4. Olga González-López: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  5. Lucinda Hensley: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  6. John M Cullen: College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America. ORCID
  7. David R McGivern: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. ORCID
  8. Mami Matsuda: Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  9. Ryosuke Suzuki: Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan. ORCID
  10. Ganes C Sen: Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  11. Asuka Hirai-Yuki: Management Department of Biosafety and Laboratory Animal, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  12. Jason K Whitmire: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. ORCID
  13. Stanley M Lemon: Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. ORCID

Abstract

HAV-infected Ifnar1-/- mice recapitulate many of the cardinal features of hepatitis A in humans, including serum alanine aminotransferase (ALT) elevation, hepatocellular apoptosis, and liver inflammation. Previous studies implicate MAVS-IRF3 signaling in pathogenesis, but leave unresolved the role of IRF3-mediated transcription versus the non-transcriptional, pro-apoptotic activity of ubiquitylated IRF3. Here, we compare the intrahepatic transcriptomes of infected versus naïve Mavs-/- and Ifnar1-/- mice using high-throughput sequencing, and identify IRF3-mediated transcriptional responses associated with hepatocyte apoptosis and liver inflammation. Infection was transcriptionally silent in Mavs-/- mice, in which HAV replicates robustly within the liver without inducing inflammation or hepatocellular apoptosis. By contrast, infection resulted in the upregulation of hundreds of genes in Ifnar1-/- mice that develop acute hepatitis closely modeling human disease. Upregulated genes included pattern recognition receptors, interferons, chemokines, cytokines and other interferon-stimulated genes. Compared with Ifnar1-/- mice, HAV-induced inflammation was markedly attenuated and there were few apoptotic hepatocytes in livers of infected Irf3S1/S1Ifnar1-/- mice in which IRF3 is transcriptionally-inactive due to alanine substitutions at Ser-388 and Ser-390. Although transcriptome profiling revealed remarkably similar sets of genes induced in Irf3S1/S1Ifnar1-/- and Ifnar1-/- mice, a subset of genes was differentially expressed in relation to the severity of the liver injury. Prominent among these were both type 1 and type III interferons and interferon-responsive genes associated previously with apoptosis, including multiple members of the ISG12 and 2'-5' oligoadenylate synthetase families. Ifnl3 and Ifnl2 transcript abundance correlated strongly with disease severity, but mice with dual type 1 and type III interferon receptor deficiency remained fully susceptible to liver injury. Collectively, our data show that IRF3-mediated transcription is required for HAV-induced liver injury in mice and identify key IRF3-responsive genes associated with pathogenicity, providing a clear distinction from the transcription-independent role of IRF3 in liver injury following binge exposure to alcohol.

References

  1. Mol Endocrinol. 2006 Jun;20(6):1333-51 [PMID: 16469768]
  2. mBio. 2016 Dec 6;7(6): [PMID: 27923925]
  3. J Biol Chem. 2001 Dec 28;276(52):49077-82 [PMID: 11602613]
  4. J Hepatol. 2011 Feb;54(2):201-8 [PMID: 21056495]
  5. Cell Death Differ. 2011 Jun;18(6):925-36 [PMID: 21151029]
  6. PLoS Pathog. 2008 Sep 12;4(9):e1000151 [PMID: 18787692]
  7. PLoS One. 2020 Dec 2;15(12):e0242665 [PMID: 33264334]
  8. J Interferon Cytokine Res. 2011 Jan;31(1):173-81 [PMID: 20939681]
  9. Metabolism. 2018 Apr;81:13-24 [PMID: 29106945]
  10. Nature. 2019 Oct;574(7777):249-253 [PMID: 31578523]
  11. EMBO J. 2010 May 19;29(10):1762-73 [PMID: 20360684]
  12. J Infect Dis. 1989 Aug;160(2):209-17 [PMID: 2503564]
  13. Hepatology. 2011 Feb;53(2):649-60 [PMID: 21274885]
  14. Immunity. 2018 Jan 16;48(1):161-173.e5 [PMID: 29305140]
  15. Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16544-9 [PMID: 24052526]
  16. Oncotarget. 2016 Aug 2;7(31):49027-49041 [PMID: 27448985]
  17. Biol Cell. 2017 Feb;109(2):94-112 [PMID: 27673746]
  18. Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12448-52 [PMID: 19617565]
  19. Nat Microbiol. 2019 Jul;4(7):1096-1104 [PMID: 30988429]
  20. J Virol. 2021 Mar 10;: [PMID: 33692213]
  21. Cell Syst. 2015 Dec 23;1(6):417-425 [PMID: 26771021]
  22. J Hepatol. 2017 Sep 5;: [PMID: 28887164]
  23. J Virol. 2002 Jun;76(11):5532-9 [PMID: 11991981]
  24. Nat Genet. 2003 Jul;34(3):267-73 [PMID: 12808457]
  25. PLoS Pathog. 2021 Jan 21;17(1):e1009220 [PMID: 33476326]
  26. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [PMID: 16199517]
  27. J Hepatol. 2021 Jul 29;: [PMID: 34331968]
  28. J Hepatol. 2020 Sep;73(3):640-650 [PMID: 32247824]
  29. Annu Rev Immunol. 2009;27:147-63 [PMID: 19302037]
  30. J Biol Chem. 2016 Dec 23;291(52):26794-26805 [PMID: 27810900]
  31. Immunity. 2016 May 17;44(5):1151-61 [PMID: 27178468]
  32. PLoS One. 2014 Jan 31;9(1):e87906 [PMID: 24498220]
  33. J Hepatol. 2019 May;70(5):974-984 [PMID: 30710579]
  34. PLoS Pathog. 2019 Apr 8;15(4):e1007674 [PMID: 30958867]
  35. J Virol. 2015 Mar;89(5):2462-8 [PMID: 25428874]
  36. PLoS One. 2014 Apr 11;9(4):e94501 [PMID: 24727952]
  37. Science. 2016 Sep 30;353(6307):1541-1545 [PMID: 27633528]
  38. Cold Spring Harb Perspect Med. 2019 Jan 2;9(1): [PMID: 29661811]
  39. Nat Rev Immunol. 2012 Feb 24;12(3):201-13 [PMID: 22362353]
  40. J Biol Chem. 2011 Mar 4;286(9):7257-66 [PMID: 21190939]
  41. Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11223-8 [PMID: 21690403]
  42. J Exp Med. 2012 Jul 30;209(8):1481-92 [PMID: 22753925]

Grants

  1. R01 AI143894/NIAID NIH HHS
  2. R01 AI103083/NIAID NIH HHS
  3. P30 CA016086/NCI NIH HHS
  4. R01 AI138337/NIAID NIH HHS
  5. R01 AI131685/NIAID NIH HHS
  6. R01 AA027456/NIAAA NIH HHS
  7. R01 AI150095/NIAID NIH HHS
  8. R01 CA068782/NCI NIH HHS

MeSH Term

Animals
Disease Models, Animal
Hepatitis A
Interferon Regulatory Factor-3
Liver
Mice
Mice, Knockout
Transcriptome

Chemicals

Interferon Regulatory Factor-3
Irf3 protein, mouse

Word Cloud

Created with Highcharts 10.0.0micelivergenesIfnar1-/-apoptosisinflammationIRF3-mediatedinjurytypehepatitisIRF3associatedincludingalaninehepatocellularroletranscriptionversusinfectedMavs-/-identifyhumandiseaseinterferonsHAV-inducedIrf3S1/S1Ifnar1-/-severity1IIIpathogenicityHAV-infectedrecapitulatemanycardinalfeatureshumansserumaminotransferaseALTelevationPreviousstudiesimplicateMAVS-IRF3signalingpathogenesisleaveunresolvednon-transcriptionalpro-apoptoticactivityubiquitylatedcompareintrahepatictranscriptomesnaïveusinghigh-throughputsequencingtranscriptionalresponseshepatocyteInfectiontranscriptionallysilentHAVreplicatesrobustlywithinwithoutinducingcontrastinfectionresultedupregulationhundredsdevelopacutecloselymodelingUpregulatedincludedpatternrecognitionreceptorschemokinescytokinesinterferon-stimulatedComparedmarkedlyattenuatedapoptotichepatocytesliverstranscriptionally-inactiveduesubstitutionsSer-388Ser-390AlthoughtranscriptomeprofilingrevealedremarkablysimilarsetsinducedsubsetdifferentiallyexpressedrelationProminentamonginterferon-responsivepreviouslymultiplemembersISG122'-5'oligoadenylatesynthetasefamiliesIfnl3Ifnl2transcriptabundancecorrelatedstronglydualinterferonreceptordeficiencyremainedfullysusceptibleCollectivelydatashowrequiredkeyIRF3-responsiveprovidingcleardistinctiontranscription-independentfollowingbingeexposurealcoholmurinemodelA

Similar Articles

Cited By